AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Realbotix Corp.

$0.2 -$0.13 (-40.39%)
OTC · 15 Sep 2026 18:00 UTC
Previous Close
$0.2
Day Range
$0.2$0.2
Year Range
$0.17$0.47
Market Cap
42.83M
AVG Volume
234.7K
Trailing/Forward PE
-9.47/-
PEG ratio
0.13
Dividend Yield
-
Next Earnings Date
2026-10-27
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
01M2M3M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q3712.53K
26 Q2982.67K
26 Q11.52M
25 Q42.02M
25 Q32.7M
25 Q22.4M
25 Q11.92M
24 Q41.28M
24 Q3892.75K
24 Q2708.92K
Net Income (USD) · TTM
-20M-15M-10M-5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q3-3.63M
26 Q2-1.85M
26 Q1-7.08M
25 Q4-4.82M
25 Q3-15.94M
25 Q2-18.46M
25 Q1-9.77M
24 Q4-8.56M
24 Q3-5.81M
24 Q2-3.99M
Operating Income (USD) · TTM
-15M-10M-5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q3-7.35M
26 Q2-5.73M
26 Q1-8.55M
25 Q4-6.23M
25 Q3-7.92M
25 Q2-10.51M
25 Q1-5.78M
24 Q4-7.1M
24 Q3-4.29M
24 Q2-2.73M
EBITDA (USD) · TTM
-15M-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q3-6.79M
26 Q2-5.14M
26 Q1-7.86M
25 Q4-5.59M
25 Q3-9.75M
25 Q2-12.49M
25 Q1-8.03M
24 Q4-7.25M
24 Q3-890.51K
24 Q2675.67K
Cash Flows (USD) · TTM
-8M-6M-4M-2M02M22 Q322 Q423 Q123 Q223 Q324 Q124 Q226 Q126 Q226 Q3
XBOTF Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q3-6.64M
26 Q2-5.12M
26 Q1-5.05M
24 Q2-2.94M
24 Q1-2.42M
23 Q3-1.98M
23 Q2115.36K
23 Q1-3.73M
22 Q4-5.07M
22 Q3-7.36M
EPS (USD) · TTM
-0.15-0.1-0.05-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q3-0.02
26 Q2-0.01
26 Q1-0.03
25 Q4-0.02
25 Q3-0.09
25 Q2-0.11
25 Q1-0.06
24 Q4-0.05
24 Q3-0.05
24 Q2-0.03
Expenses (USD) · TTM
-2M02M4M6MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
24 Q10
23 Q34.62K
23 Q24.62K
23 Q1-1.61M
22 Q4-12.7K
22 Q3-17.32K
26 Q3742.09K
26 Q2398.26K
26 Q1-237.88K
25 Q40
25 Q33.74M
25 Q24.1M
25 Q13.29M
24 Q42.49M
24 Q32.93M
24 Q22.57M
Shares Outstanding (USD) · TTM
-800K-600K-400K-200K0200KBuybacks (Repurchases)Stock-Based Compensation22 Q322 Q423 Q123 Q223 Q324 Q124 Q226 Q126 Q226 Q3
XBOTF Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q3-648.52K
26 Q2-760.92K
26 Q1-377.03K
24 Q216.96K
24 Q1-123.88K
23 Q3-149.09K
23 Q2-306.45K
23 Q1-304.58K
22 Q4-273.33K
22 Q3-576.43K
Free Cash Flow Yield
-60%-40%-20%0%20%med -16.68%Jun 23Oct 23Jan 24May 24Aug 24Jun 26Sep 26
XBOTF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-11.98%
Sep 26-11.98%
Sep 26-11.53%
Aug 26-11.13%
Aug 26-10.75%
Aug 26-11.18%
Aug 26-11.13%
Jul 26-11.43%
Jul 26-9.83%
Jul 26-10.4%
Jul 26-8.8%
Jul 26-8.66%
Jun 26-16.3%
Jun 26-15.88%
Jun 26-15.56%
Jun 26-15.52%
May 26-12.77%
May 26-13.65%
May 26-14.52%
May 26-14.11%
May 26-13.13%
Apr 26-12.92%
Apr 26-13.35%
Apr 26-14.67%
Apr 26-15.36%
Sep 24-31.1%
Sep 24-31.18%
Sep 24-30.02%
Sep 24-28.81%
Aug 24-29.09%
Aug 24-26.72%
Aug 24-26.38%
Aug 24-24.39%
Aug 24-22.11%
Jul 24-20.86%
Jul 24-20.25%
Jul 24-19.45%
Jul 24-19.85%
Jun 24-16.25%
Jun 24-15.77%
Jun 24-13.23%
Jun 24-15.57%
May 24-17.92%
May 24-16.87%
May 24-17.23%
May 24-22.66%
May 24-23.15%
Apr 24-22.46%
Apr 24-21.54%
Apr 24-22.75%
Apr 24-21.77%
Mar 24-15.29%
Mar 24-16.66%
Mar 24-16.6%
Mar 24-15.04%
Mar 24-16.53%
Feb 24-20.09%
Feb 24-20.29%
Feb 24-20.67%
Feb 24-22%
Jan 24-16.7%
Jan 24-17.49%
Jan 24-16.53%
Jan 24-14.11%
Dec 23-12.63%
Dec 231.02%
Dec 231.13%
Dec 231.08%
Dec 231.07%
Nov 231.06%
Nov 231.13%
Nov 231.24%
Nov 231.08%
Oct 231.07%
Oct 231.12%
Oct 231.15%
Oct 231.04%
Sep 231.01%
Sep 23-32.31%
Sep 23-33.52%
Sep 23-33.29%
Sep 23-33.54%
Aug 23-29.71%
Aug 23-30.78%
Aug 23-27.91%
Aug 23-23.78%
Jul 23-20.79%
Jul 23-18.62%
Jul 23-20.5%
Jul 23-25.26%
Jun 23-26.72%
Jun 23-35.65%
Jun 23-47.15%
Jun 23-44.57%
Jun 23-41.08%
May 23-45.61%
May 23-48.25%
May 23-46.02%
May 23-41.41%
Apr 23-42.73%
Price to Sales
020406080med 23.62Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XBOTF Price to Sales by quarter
PeriodPrice to Sales
Sep 2643.51
Sep 2643.51
Sep 2645.2
Aug 2646.83
Aug 2648.5
Aug 2646.63
Aug 2646.83
Jul 2645.6
Jul 2653.03
Jul 2650.11
Jul 2659.25
Jul 2660.21
Jun 2620.37
Jun 2620.91
Jun 2621.34
Jun 2621.4
May 2626
May 2624.32
May 2622.87
May 2623.54
May 2625.29
Apr 2625.7
Apr 2624.86
Apr 2622.63
Apr 2621.61
Mar 2615.08
Mar 2614.94
Mar 2615.89
Mar 2614.04
Feb 2614.09
Feb 2614.67
Feb 2615.38
Feb 2616.86
Jan 2618.22
Jan 2620.96
Jan 2619.34
Jan 2619.29
Jan 2623.05
Dec 2522.36
Dec 2519.52
Dec 2519.92
Dec 2521.11
Nov 2522.7
Nov 2521.04
Nov 2518.5
Nov 2518.51
Oct 2522.96
Oct 2523.7
Oct 2530.17
Oct 2531.1
Oct 2526.35
Sep 2529.33
Sep 2530.11
Sep 2524.72
Sep 2524.72
Aug 2526.49
Aug 2523.89
Aug 2524.17
Aug 2525.54
Aug 2519.62
Jul 2521.46
Jul 2523.15
Jul 2523.37
Jul 2525.78
Jun 2530.68
Jun 2528.66
Jun 2529.69
Jun 2526.83
May 2530.71
May 2536.18
May 2529.69
May 2528.75
May 2520.47
Apr 2519.83
Apr 2518.43
Apr 2519.9
Apr 2516.77
Mar 2527.25
Mar 2528.12
Mar 2530.35
Mar 2531.6
Feb 2532.62
Feb 2538.4
Feb 2545.83
Feb 2540.07
Jan 2532.08
Jan 2534.38
Jan 2539.63
Jan 2551.65
Jan 2520.81
Dec 2421
Dec 2417.78
Dec 2415.7
Dec 2415.4
Nov 2413.55
Nov 2414.65
Nov 2417.06
Nov 2418.51
Nov 2418.18
Oct 2415.26
EV/EBITDA
-1001020med 4.26Aug 22Oct 22Jan 23Oct 23Apr 24Jul 24Sep 24
XBOTF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2410.71
Sep 2410.68
Sep 2411.21
Sep 2411.82
Aug 2411.68
Aug 2413
Aug 2413.22
Aug 2414.56
Aug 2416.41
Jul 2417.59
Jul 2418.21
Jul 2419.09
Jul 2418.64
Jun 244.08
Jun 244.23
Jun 245.23
Jun 244.3
May 243.61
May 243.89
May 243.79
May 242.65
May 242.57
Apr 242.68
Apr 242.84
Apr 242.63
Apr 242.8
Dec 236.05
Dec 235.12
Dec 235.5
Dec 235.63
Nov 235.64
Nov 235.1
Nov 234.33
Nov 235.52
Oct 235.56
Oct 235.22
Oct 234.99
Oct 235.85
Sep 236.12
Mar 235.29
Mar 235.84
Mar 234.67
Mar 237.32
Feb 236.49
Feb 238
Feb 238.11
Feb 238.06
Jan 238.39
Jan 2311.35
Jan 237.86
Jan 234.01
Dec 222.03
Dec 22-7.76
Dec 22-7.63
Dec 22-7.45
Dec 22-6.98
Nov 22-7.08
Nov 22-6.99
Nov 22-6.98
Nov 22-6.41
Oct 22-6.43
Oct 22-6.78
Oct 22-6.7
Oct 22-5.34
Sep 22-5.68
Sep 22-1.78
Sep 22-1.45
Sep 22-1.29
Sep 22-1.22
Aug 22-1.11
Aug 22-1.04
Aug 22-0.78
Aug 22-0.71
Jul 22-0.84
Jul 22-0.88
Jul 22-0.84
Jul 22-0.7
Jul 22-0.24
Price/Operating Cashflow
80859095100med 92.71Sep 23Oct 23Oct 23Nov 23Nov 23Dec 23Dec 23
XBOTF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 2398.14
Dec 2388.53
Dec 2392.48
Dec 2393.74
Nov 2393.94
Nov 2388.35
Nov 2380.41
Nov 2392.71
Oct 2393.11
Oct 2389.61
Oct 2387.27
Oct 2396.07
Sep 2398.77
Price to Book
05101520med 6.27Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XBOTF Price to Book by quarter
PeriodPrice to Book
Sep 265.13
Sep 265.13
Sep 265.33
Aug 265.52
Aug 265.72
Aug 265.5
Aug 265.52
Jul 265.38
Jul 266.25
Jul 265.91
Jul 266.98
Jul 267.1
Jun 264.02
Jun 264.13
Jun 264.21
Jun 264.22
May 265.13
May 264.8
May 264.51
May 264.64
May 264.99
Apr 265.07
Apr 264.91
Apr 264.47
Apr 264.26
Mar 268.33
Mar 268.25
Mar 268.78
Mar 267.75
Feb 267.78
Feb 268.1
Feb 268.5
Feb 269.31
Jan 2610.06
Jan 2611.58
Jan 2610.68
Jan 2610.66
Jan 2612.73
Dec 2512.73
Dec 2511.12
Dec 2511.34
Dec 2512.02
Nov 2512.92
Nov 2511.98
Nov 2510.53
Nov 2510.54
Oct 2513.07
Oct 2513.49
Oct 2517.17
Oct 2517.71
Oct 2515
Sep 2516.32
Sep 2516.75
Sep 2513.75
Sep 2513.75
Aug 2514.74
Aug 2513.29
Aug 2513.45
Aug 2514.21
Aug 2510.91
Jul 2511.94
Jul 2512.88
Jul 2513
Jul 2514.34
Jun 256.5
Jun 256.07
Jun 256.29
Jun 255.68
May 256.51
May 257.66
May 256.29
May 256.09
May 254.34
Apr 254.2
Apr 253.9
Apr 254.22
Apr 253.55
Mar 254.36
Mar 254.5
Mar 254.86
Mar 255.06
Feb 255.22
Feb 256.15
Feb 257.34
Feb 256.41
Jan 255.14
Jan 255.5
Jan 256.35
Jan 258.27
Jan 253.33
Dec 241
Dec 240.84
Dec 240.75
Dec 240.73
Nov 240.64
Nov 240.69
Nov 240.81
Nov 240.88
Nov 240.86
Oct 240.72
Realbotix Corp.
XBOTF
Stockpicker

Video analysis: XBOTF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XBOTF

Realbotix LLC Announces Bridge Loan from Onconetix

businesswire.com · 14 Sep 2026

Realbotix LLC Announces Bridge Loan from Onconetix

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has entered into a loan agreement with Onconetix, Inc. (“Onconetix”) for an unsecured bridge loan facility in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on February 12, 2026. The bridge loan provides transa.

Realbotix and European Telecom Company Launch Pilot to Expand Robot Capabilities in Live Presentations and Events

businesswire.com · 3 Sep 2026

Realbotix and European Telecom Company Launch Pilot to Expand Robot Capabilities in Live Presentations and Events

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, today announced a pilot with a leading European telecommunications company to put its humanoid robots in front of live audiences. The program will test how Realbotix robots can deliver presentations, support events, and hold interactive conversations in real social settings — not only one-on-one exchanges, but rooms full of peo.

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

seekingalpha.com · 12 Aug 2026

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

Realbotix Reports Financial Results for Q3-2026

businesswire.com · 12 Aug 2026

Realbotix Reports Financial Results for Q3-2026

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, reports its interim financial results for the three and nine months ended June 30, 2026 (“Q3-2026”). All dollar figures are reported in United States dollars (“USD”), unless otherwise stated. Realbotix Corp. is a holding company with two independently operated subsidiaries, Realbotix LLC and Intima LLC. While both leverage embe.

Realbotix Robot to Appear on Emmy Winning Television Show

businesswire.com · 6 Aug 2026

Realbotix Robot to Appear on Emmy Winning Television Show

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading manufacturer of humanoid robots and embedded AI systems, entered into an agreement with a recognized streaming platform to feature one of its robots as a robotic character in an upcoming episode of a popular Emmy awarded television series. The appearance is significant for Realbotix and highlights the growing cultural relevance of humanoid robotics in mainstream e.

Realbotix to Release its Q3-2026 Financial Results on August 12, 2026

businesswire.com · 5 Aug 2026

Realbotix to Release its Q3-2026 Financial Results on August 12, 2026

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, is pleased to share that it will release its interim financial results for the three and nine months ended June 30, 2026 (“Q3-2026”) on August 12, 2026. An investor webinar hosted by CEO Andrew Kiguel on Zoom has been scheduled to discuss the Company's Q3-2026 financial results starting at 3:00 pm ET on August 12, 2026. Date: A.

Realbotix Corp. Provides Corporate Structure and Operations Update

gurufocus.com · 22 Jul 2026

Realbotix Corp. Provides Corporate Structure and Operations Update

[url="]Realbotix Corp.[/url] (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Company") provides an overview of its corporate and operating

Realbotix Corp. Provides Corporate Structure and Operations Update

businesswire.com · 22 Jul 2026

Realbotix Corp. Provides Corporate Structure and Operations Update

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Company") provides an overview of its corporate and operating structure. Realbotix Corp. is a holding company with two separately operated businesses: Realbotix LLC, which focuses on AI-powered humanoid robotics for commercial service sector applications, and Intima LLC, which focuses on direct-to-consumer products. Realbotix LLC and Intima LLC have different product offerings with no.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.